Stocks

Daktronics (NASDAQ: DAKT) presents investors with a complex narrative as operational wins collide with financial setbacks. The digital display manufacturer's...

The biotech sector has its eyes on Kodiak Sciences, a clinical-stage company generating both excitement and caution among investors. While...

While major banks battle for market dominance, Orrstown Financial Services has carved out a distinct niche—earning praise from both analysts...

Financial analysts are turning bullish on Equity Bancshares (NASDAQ: EQBK), with the regional bank demonstrating standout fundamentals that position it...

The second quarter of 2025 proved transformative for SoFi Technologies, with the fintech innovator delivering performance metrics that demolished analyst...

A striking divergence has emerged in Parker-Hannifin's shareholder activity, with institutional investors aggressively accumulating shares while company insiders significantly reduce...

California-based clean energy firm SunHydrogen has unveiled a breakthrough prototype—a self-contained hydrogen generator that operates entirely without grid electricity. The...

The upcoming Q2 2025 earnings release represents a make-or-break moment for Chinese EV manufacturer XPeng. After a year of significant...

After weeks of downward pressure, American Assets Trust (AAT) is displaying tentative signals of recovery. While the real estate investment...

The Chinese biotech firm I-Mab (NASDAQ: IMAB) is making waves with its experimental cancer therapy, but investors should brace for...